Clinical Trial Update: 68Ga-P3 PET/CT Imaging in Malignancy [NA]

View source ↗

Summary

An ongoing clinical trial evaluating 68Ga-P3 PET/CT imaging in malignancies is currently recruiting at Peking University First Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms

Drugs mentioned

• Ga-68-P3 (Gallium-68 labeled P3 radiotracer)

Snippet

Sponsor: Peking University First Hospital | Conditions: Neoplasms | NA | Status: RECRUITING